FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNanollose Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
NC6.AX
Nanollose Limited Stock AnalysisComprehensive stock analysis for Nanollose Limited (NC6.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNC6.AX
NC6.AX
Nanollose Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
NC6.AX
  1. Home
  2. Stocks
  3. Nanollose Limited

Nanollose Limited

🇦🇺NC6.AX•ASX

Nanollose Limited

🇦🇺NC6.AX•ASX

Your view on NC6.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Nanollose Limited

Industry
Biotechnology
Sector
Healthcare
CEO
Andrew Moullin
Headquarters
145 Stirling Highway, Nedlands, WA, AU
Industry
Biotechnology
Sector
Healthcare
CEO
Andrew Moullin
Headquarters
145 Stirling Highway, Nedlands, WA, AU
Description

Nanollose Limited is an Australian biomaterials enterprise dedicated to the research, development, and commercialization of microbial nanocellulose technology.

Its product line features Nullarbor Fibre, an innovative lyocell fibre produced without relying on trees, and Jelli Grow, an eco-friendly substitute for seed germination and cultivating plants. These materials find applications across various sectors, including textiles, nonwoven fabrics, and other industries.

Established in 2014, the company's headquarters are situated in Nedlands, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Nanollose Limited. Starting points for Nanollose Limited: EPS -AUD 0.0060, beta 0.68 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Nanollose Limited. Nanollose Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Nanollose Limited. Trailing twelve-month EPS for Nanollose Limited stands at -AUD 0.0060. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Nanollose Limited. Nanollose Limited has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NC6.AX18 companies
Compare NC6.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AVE.AXAvecho Biotechnology LimitedHealthcareBiotechnology—
BTC.AXBTC Health LimitedHealthcareBiotechnology—
FRE.AXFirebrick Pharma LimitedHealthcareDrug Manufacturers - General—
IMC.AXImmuron LimitedHealthcareBiotechnology—
IME.AXImExHS LimitedHealthcareMedical - Diagnostics & Research—
NTI.AXNeurotech International LimitedHealthcareBiotechnology—
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
PSYBFPsyBio Therapeutics Corp.HealthcareOTC$1,275
PTCHFPureTech Health plcHealthcareOTC$410.4M
PTCTPTC Therapeutics, Inc.HealthcareNASDAQ$5.0B
PTGXProtagonist Therapeutics, Inc.HealthcareNASDAQ$8.3B
PTHSPelthos Therapeutics Inc.HealthcareAMEX$27.9M
PTIXProtagenic Therapeutics, Inc.HealthcareNASDAQ$470,654
PTNPalatin Technologies, Inc.HealthcareNASDAQ$9.2M
PTX.AXPrescient Therapeutics LimitedHealthcareASX—
PULMPulmatrix, Inc.HealthcareNASDAQ$4.9M
PVCTProvectus Biopharmaceuticals, Inc.HealthcareOTC$18.7M
PVLAPalvella Therapeutics, Inc.HealthcareNASDAQ$2.1B
PXMDPaxMedica, Inc. Common StockHealthcareOTC$37,879
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Nanollose Limited.

NC6.AX AnalysisWeak
Past
3
Growth
1
Health
1
Profit
1
Value
1